Companies: 10,795·Total market cap: $144.5T
Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc.

UPCNASDAQHealthcare● Active
$3.62
+$0.35(+10.79%)
Market Cap$2040917
P/E Ratio—
52W High$11
52W Low$2
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Universe Pharmaceuticals Inc. (UPC) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001809616 · UPC · NASDAQ · as of Jun 9, 2026

Filing snapshot

103
Total Filings
4
Latest Form
2026-05-21
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001809616 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-01-29
Fiscal Year End
Jan 29, 2026
Accession No.
0001213900-26-009000
Primary Document
ea0273969-20f_universe.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001809616 · Accession 0001213900-26-009000

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-14
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-05-21
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-14
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-16
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-02-11
View
20-FAnnual Report (Foreign Issuer)
ANNUAL REPORT
2026-01-29
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-01-07
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-09-03
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-08-26
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-07-29
View
Showing 1–15 of 102 filingsForm 4 / 144 hidden· 103 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001809616  |  Exchange: NASDAQ · Healthcare

Universe Pharmaceuticals Inc. (NASDAQ: UPC) has submitted 103 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001809616, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Universe Pharmaceuticals Inc.'s most comprehensive regulatory disclosure. The most recent Universe Pharmaceuticals Inc. 10-K was filed on 2026-01-29 for fiscal year ending 2026. Historical UPC 10-K annual reports are available from 2020 through 2026.

Investors researching Universe Pharmaceuticals Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
NKGN SEC Filings →MLEC SEC Filings →ELAB SEC Filings →BJDX SEC Filings →NCEL SEC Filings →TIVC SEC Filings →SHPH SEC Filings →WINT SEC Filings →
→ UPC Financials→ UPC Earnings→ UPC Insider Trades

Frequently Asked Questions

UPC SEC Filings · 8 questions

Universe Pharmaceuticals Inc. (UPC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 103 filings and access original documents at no cost. Universe Pharmaceuticals Inc.'s CIK is 0001809616.

UPC SEC filingsUniverse Pharmaceuticals Inc. SEC documentsfind UPC 10-K